...
首页> 外文期刊>Transplantation Proceedings >Portal versus systemic venous drainage of the pancreatic graft: The effect on glucose metabolism in pancreas and kidney transplant recipients
【24h】

Portal versus systemic venous drainage of the pancreatic graft: The effect on glucose metabolism in pancreas and kidney transplant recipients

机译:胰移植的门静脉和全身静脉引流:对胰腺和肾脏移植受者葡萄糖代谢的影响

获取原文
获取原文并翻译 | 示例

摘要

Two different methods of graft venous drainage are used in pancreas transplantation: portal (PVD) and systemic (SVD). PVD is considered to be more physiologic due to its similarity to venous outflow of the native pancreas. The aim of our study was to compare glucose metabolism in Type 1 diabetic recipients of kidney and pancreatic grafts with PVD versus SVD by intravenous glucose tolerance test (IVGTT). We examined 28 insulin-independent patients after simultaneous pancreas and kidney transplantation: 14 recipients with PVD of the pancreatic graft and 14 with SVD after a mean post-transplant period of 1 year. All recipients had stable good function of the kidney graft. Fasting glycemia, insulin levels, glycosylated hemoglobin (HbA1c), and standard IVGTT with coefficient of glucose assimilation (KG) calculation were assessed. Insulin sensitivity and production were evaluated using the homeostasis model assessment (homeostasis model assessment of insulin resistance [HOMA-IR], homeostasis model assessment of B-cell function [HOMA-B]). Total C-peptide and insulin secretions were calculated as areas under the curves (AUCs) from the serum levels during the IVGTT. PVD and SVD groups did not differ in age, body mass index (BMI) and duration of post-transplantation period (P ≥.05). We did not find any significant difference in fasting glycemia, HbA1c, KG, HOMA-IR, parameters of C-peptide level, fasting insulin level, and response during IVGTT. HOMA-B and AUC of insulin level were higher in the SVD group (45.1 ± 35.1 versus 19.8 ± 15.5, P =.03 and 1075 ± 612 versus 1799 ± 954 mIU/L/60 minutes, P .03, respectively). In the PVD group, 1 patient had an abnormal response to the glucose stimulus, 8 patients had an impaired glucose tolerance, and 5 patients had a normal glucose tolerance. In the SVD group, an abnormal response was present in none, impaired glucose tolerance in 4, and normal glucose tolerance in 10 recipients. Athough this was not a prospectively randomized trial, we conclude that the change of surgical technique from SVD to PVD did not lead to any substantial change in terms of glucose tolerance.
机译:胰腺移植使用两种不同的移植静脉引流方法:门静脉(PVD)和全身性(SVD)。由于PVD与天然胰腺的静脉流出相似,因此被认为更具生理性。我们研究的目的是通过静脉葡萄糖耐量试验(IVGTT)比较PVD与SVD在1型糖尿病肾和胰腺移植物中的葡萄糖代谢。我们在同时进行胰腺和肾脏移植后检查了28位胰岛素非依赖性患者:平均移植后1年后,有14位胰腺移植物的PVD接受者和14位SVD的接受者。所有接受者均具有稳定的肾移植良好功能。评估空腹血糖,胰岛素水平,糖基化血红蛋白(HbA1c)和标准IVGTT,并计算葡萄糖同化系数(KG)。使用稳态模型评估(胰岛素抵抗的稳态模型评估[HOMA-IR],B细胞功能的稳态模型评估[HOMA-B])评估胰岛素敏感性和生产。从IVGTT期间的血清水平计算总C肽和胰岛素分泌,以曲线下面积(AUC)表示。 PVD和SVD组的年龄,体重指数(BMI)和移植后持续时间无差异(P≥.05)。我们在空腹血糖,HbA1c,KG,HOMA-IR,C肽水平参数,空腹胰岛素水平和IVGTT期间的反应方面未发现任何显着差异。 SVD组的胰岛素水平的HOMA-B和AUC较高(分别为45.1±35.1与19.8±15.5,P = .03和1075±612与1799±954 mIU / L / 60分钟,P <.03)。在PVD组中,1例患者对葡萄糖刺激的反应异常,8例患者的葡萄糖耐量受损,5例患者的葡萄糖耐量正常。在SVD组中,没有异常反应出现,有4位患者的糖耐量降低,有10位接受者的葡萄糖耐量正常。尽管这不是一项前瞻性随机试验,但我们得出的结论是,将手术技术从SVD改变为PVD不会导致葡萄糖耐量方面的任何实质性改变。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号